NeuroAD Therapy System for Alzheimer DiseaseMarch 7, 2018
NeuroAD is noninvasive system that combines repetitive transcranial magnetic stimulation with cognitive training to treat mild-to-moderate Alzheimer disease. Transcranial magnetic stimulation (TMS) is a neurostimulation and neuromodulation method that uses electromagnetic induction of electric fields in the brain. TMS works by passing a current through a wire coil placed on the scalp; the transient current produces a magnetic field, which induces electric current in the underlying brain. It is proposed that this stimulation induces long-term potentiation, which is associated with learning and memory processes, and makes these areas of the brain more receptive to cognitive training.
If you have a Hayes login, click here to view the full report on the Knowledge Center.